2021 global life sciences outlook
Possibility is now reality, sustaining forward momentum
Navigating the pandemic has been an all-encompassing, once-in-a-lifetime challenge. Globally, life sciences companies responded with leadership and are emerging stronger. How will life sciences companies continue to respond and what areas can they build resiliency going forward?
Attract, engage, and build loyalty
How actionable segmentation can provide valuable insights about your health care customers
As health care companies cater to activated and empowered customers, understanding differences in their attitudes, behaviors, and needs is important. Intelligent segmentation can be essential for delivering a unique customer experience.
The future unmasked
Predicting the future of healthcare and life sciences in 2025
What does the future hold for the life sciences and healthcare industry? Our latest predictions report looks ahead to the year 2025 to help you see what’s coming and to keep your organisation moving forward.
Securing trust in the global COVID-19 supply chain
From development and delivery to acceptance and administration
COVID-19 vaccines and therapeutics, and the associated medical devices and consumables, present an urgent need for a protected supply chain and a system of traceability built around globally identified products.
Findings from the Deloitte 2019 Health Care CEO Perspectives Study
Accelerating change is now a basic feature of the health care industry. Deloitte’s discussions with CEOs across the industry offer insights into drivers of change, priorities, and worries, and how the definition of success is evolving.